Back

Subcutaneous GP IIb/IIIa inhibition

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon? Antiplatelet Drugs ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Jurrien M ten Berg

St Antonius Hospital, Nieuwegein (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Subcutaneous P2Y12 inhibition
Professor R. Storey (Sheffield, GB)
Slides Video
Presentation thumbnail
Glycoprotein VI inhibition
Professor C. Christersson (Uppsala, SE)
Slides Video
Presentation thumbnail
FXIa inhibition
Professor D. Gorog (London, GB)
Slides Video
Presentation thumbnail
Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon? - discussion
Video

Access the full session

Session thumbnail
Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon?
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Novel antithrombotics: what’s on the horizon?
thumbnail
Congress Presentation
Injectable antiplatelet therapies: what's new?
thumbnail
Congress Presentation
Pre-hospital GP IIb/IIIa-inhibitor in STEMI: time for a revival ?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources